These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29331492)

  • 1. Prognostic Value of the Expression of DNA Repair-Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients.
    Zhang Y; Wu H; Yang F; Ning J; Li M; Zhao C; Zhong S; Gu K; Wang H
    Am J Pathol; 2018 Feb; 188(2):367-377. PubMed ID: 29331492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
    Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
    World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
    Suh KJ; Ryu HS; Lee KH; Kim H; Min A; Kim TY; Yang Y; Lee HB; Moon HG; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA
    Breast Cancer Res Treat; 2019 May; 175(1):117-127. PubMed ID: 30671767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of BRCA1 expression in gastric cancer.
    Chen W; Wang J; Li X; Li J; Zhou L; Qiu T; Zhang M; Liu P
    Med Oncol; 2013 Mar; 30(1):423. PubMed ID: 23292835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of Runx2 mediating alcohol-induced Brf1 expression and RNA Pol III gene transcription.
    Hong Z; Fang Z; Lei J; Shi G; Zhang Y; He Z; Li B W; Zhong S
    Chem Biol Interact; 2020 May; 323():109057. PubMed ID: 32198086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
    Thike AA; Tan PH; Ikeda M; Iqbal J
    Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma.
    Pádua JDB; Mariano CFA; Fabro AT; Tirapelli DPDC; Sankarankutty AK; Dos Santos JS; Brunaldi MO
    J Histochem Cytochem; 2022 Mar; 70(3):199-210. PubMed ID: 34978208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer.
    Wei J; Costa C; Ding Y; Zou Z; Yu L; Sanchez JJ; Qian X; Chen H; Gimenez-Capitan A; Meng F; Moran T; Benlloch S; Taron M; Rosell R; Liu B
    J Natl Cancer Inst; 2011 Oct; 103(20):1552-6. PubMed ID: 21862729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers.
    Wang GH; Zhao CM; Huang Y; Wang W; Zhang S; Wang X
    Hum Pathol; 2018 Jan; 71():135-144. PubMed ID: 29126833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of DNA Damage Response Markers in Early-Onset or Familial Gastric Cancers.
    Kim HS; Kim JW; Hwang IG; Lee HS; Kim WH
    Asian Pac J Cancer Prev; 2019 May; 20(5):1369-1376. PubMed ID: 31127894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Krüppel-Like Factor 7 is a Marker of Aggressive Gastric Cancer and Poor Prognosis.
    Jiang Z; Yu T; Fan Z; Yang H; Lin X
    Cell Physiol Biochem; 2017; 43(3):1090-1099. PubMed ID: 28977783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.
    Wang D; Wang L; Zhou J; Pan J; Qian W; Fu J; Zhang G; Zhu Y; Liu C; Wang C; Jin Z; He Z; Wu J; Shi B
    PLoS One; 2014; 9(11):e113754. PubMed ID: 25412184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
    Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.
    Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z
    Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy.
    Wu X; Zhou F; Ji X; Ren K; Shan Y; Mao X; Fen Y; Chen R; Ding H; Fu X
    Future Oncol; 2017 Dec; 13(29):2691-2696. PubMed ID: 28972404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer.
    Grabsch H; Dattani M; Barker L; Maughan N; Maude K; Hansen O; Gabbert HE; Quirke P; Mueller W
    Clin Cancer Res; 2006 Mar; 12(5):1494-500. PubMed ID: 16533773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
    Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
    Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
    Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.